Catalyst Wire Dossier Catalyst Wire Dossier

GZ389988

GZ389988 · Genzyme, a Sanofi Company
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GZ389988, covering 2016-08-17 to 2022-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Proof-of-concept Study to Assess the Efficacy, Tolerability and Safety of a Single Intraarticular Dose of GZ389988 Versus Placebo in Patients With Painful Osteoarthritis of the Knee [Phase 2]

See pricing